HEP Investigating Algae Extract for Cholesterol Benefits
November 20, 2011
AlgaeIndustryMagazine.com
rom Marketwire, the board of directors of Health Enhancement Products, Inc., a Scottsdale, AZ-based food ingredients and nutraceutical enterprise, has authorized an expanded study of its algae extracts.
Since May of 2011, the Company has been working with Battelle, the world’s largest independent research and development organization, to isolate the active molecules in its proprietary algae extract, specifically those natural compounds responsible for supporting a healthy cholesterol balance. Over the intervening months, Battelle research scientists have conducted a series of experiments to separate bioactive fractions of the algae extract in order to isolate and further characterize the bioactive components.
That program has resulted in a number of isolates that can now be tested in vivo. The in vivo portion of this expanded research project about to commence will be carried out in several steps. The isolated samples will be administered to test subjects over the course of 30 days, after which an evaluation process will identify those samples with bioactivity. Battelle scientists will subject those samples to further refinement and validation, or proceed directly to a final analysis.
In February of 2011, Health Enhancement filed a global PCT patent application specifically detailing the method of cholesterol regulation. In October of 2010, the Company was issued a US patent for its unique and novel method of extracting the active compounds from its proprietary algae culture. The Company intends to move forward with a product development plan created by consulting group Great Northern & Reserve Partners.
From Marketwire, the board of directors of Health Enhancement Products, Inc., a Scottsdale, AZ-based food ingredients and nutraceutical enterprise, has authorized an expanded study of its algae extracts.
Since May of 2011, the Company has been working with Battelle, the world’s largest independent research and development organization, to isolate the active molecules in its proprietary algae extract, specifically those natural compounds responsible for supporting a healthy cholesterol balance. Over the intervening months, Battelle research scientists have conducted a series of experiments to separate bioactive fractions of the algae extract in order to isolate and further characterize the bioactive components.
That program has resulted in a number of isolates that can now be tested in vivo. The in vivo portion of this expanded research project about to commence will be carried out in several steps. The isolated samples will be administered to test subjects over the course of 30 days, after which an evaluation process will identify those samples with bioactivity. Battelle scientists will subject those samples to further refinement and validation, or proceed directly to a final analysis.
In February of 2011, Health Enhancement filed a global PCT patent application specifically detailing the method of cholesterol regulation. In October of 2010, the Company was issued a US patent for its unique and novel method of extracting the active compounds from its proprietary algae culture. The Company intends to move forward with a product development plan created by consulting group Great Northern & Reserve Partners.
Go to 
Page
Copyright ©2010-2011 AlgaeIndustryMagazine.com. All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.
Visit the A.I.M. Archives
FREE Algae News & Updates
